ATLAS / Macro Radar / Reporting / TELO

Telomir Pharmaceuticals, Inc. (TELO) reporting calendar

Telomir Pharmaceuticals, Inc. files periodic reports with the SEC as TELO on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open TELO market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001493152-26-023010
10-K31 Dec 202517 Mar 202676 days0001493152-26-010625
10-Q30 Sep 202510 Nov 202541 days0001493152-25-021496
10-Q30 Jun 202514 Aug 202545 days0001641172-25-023970
10-Q31 Mar 202514 May 202544 days0001641172-25-010298
10-K31 Dec 20244 Feb 202535 days0001493152-25-004872
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044749
10-Q30 Jun 202413 Aug 202444 days0001493152-24-031606
10-Q31 Mar 202413 May 202443 days0001493152-24-018909
10-K31 Dec 202329 Mar 202489 days0001493152-24-012049

Source: SEC EDGAR company submissions for CIK 0001971532. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.